Related Experiment Video
Updated: Aug 15, 2026

09:57
Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
Published on: February 14, 2011
Histoplasmosis in AIDS: advances in management
1Infectious Disease Associates of Kansas City, Missouri, USA.
AIDS Patient Care and Stds
|May 22, 2001
Summary
Histoplasmosis, a common infection in HIV patients, has seen a decline with better antiretroviral therapy. It is treated with amphotericin B or itraconazole, with itraconazole recommended for lifelong maintenance and primary prophylaxis.
Area of Science:
- Infectious Diseases
- Immunology
- Public Health
Background:
- Histoplasmosis is a frequent opportunistic infection in individuals with Human Immunodeficiency Virus (HIV) in endemic regions.
- The incidence of histoplasmosis has decreased, correlating with advancements in antiretroviral therapy (ART).
- Infections can arise from new exposures or reactivation of latent Histoplasma capsulatum.
Purpose of the Study:
- To review the epidemiology, risk factors, clinical presentation, diagnosis, and management of histoplasmosis in HIV-infected patients.
- To highlight the impact of antiretroviral therapy on histoplasmosis incidence.
- To outline current treatment and prophylaxis strategies.
Main Methods:
- Review of existing literature on histoplasmosis in HIV-infected populations.
- Analysis of factors influencing incidence, including CD4 counts and antiretroviral therapy.
- Summary of diagnostic methods and therapeutic approaches.
Main Results:
- Major risk factors include low CD4 counts (< or = 150/microL), positive serology, and exposure to chicken coops.
- Suboptimal antiretroviral therapy may also be a risk factor.
- Diagnosis relies on cultures, antigen detection, or histopathology.
- Treatment involves amphotericin B or itraconazole for induction, followed by lifelong itraconazole maintenance.
- Itraconazole is effective for primary prophylaxis in patients with CD4 counts < or = 150/microL.
Conclusions:
- Antiretroviral therapy has significantly impacted the incidence of histoplasmosis in HIV patients.
- Prompt diagnosis and appropriate treatment, including lifelong maintenance and prophylaxis, are crucial for managing histoplasmosis.
- Understanding risk factors and clinical manifestations aids in early detection and intervention.
Related Concept Videos
Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Toxoplasmosis
Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Trichomoniasis
Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.

